73.20.Z - Market research and public opinion polling
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
52.10.B - Warehousing and storage of other goods
58.14.Z - Publishing of journals and periodicals
63.99.Z - Other information service activities not elsewhere classified
85.60.Z - Educational support activities
96.09.Z - Other personal service activities not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 1,1 | 1,2 | 1,2 | 2,3 |
Liabilities and provisions | 0,2 | 0,2 | 0,3 | 35 |
Equity | 0,2 | 0,1 | 0 | -60 |
Total assets | 0,4 | 0,3 | 0,3 | 2,8 |
Cash and cash equivalents | 0,1 | 0,1 | 0,1 | 62,5 |
Depreciation | 0 | 0 | 0 | -30,6 |
Gross profit / loss | 0,1 | -0,1 | -0,1 | 6,8 |
EBITDA | 0,1 | 0 | 0 | -30,2 |
Net profit / loss | 0,1 | -0,1 | -0,1 | 6,8 |
Operating profit (EBIT) | 0,1 | -0 | -0 | 30,7 |
Current assets | 0,3 | 0,2 | 0,3 | 15,2 |
% | % | % | p.p. | |
Return on equity (ROE) | 46,7 | -64,4 | -150,2 | -85,8 |
Return on sales (ROS) | 7,4 | -5,7 | -5,2 | 0,5 |
Equity ratio | 43,8 | 33,9 | 13,2 | -20,7 |
EBITDA margin | 12,9 | 0,3 | 0,2 | -0,1 |
Gross profit margin | 7,4 | -5,7 | -5,2 | 0,5 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 21 | 29 | 27 | -2 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.